Breaking News

WuXi Biologics to Build Largest Bio-Mfg. Facility in Ireland

Investing €325 million in a total of 48,000 L fed-batch and 6,000 L perfusion bioreactor capacity

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics is investing €325 million in a new biologics drug substance manufacturing facility on the Industrial Development Authority’s (IDA) greenfield site in Dundalk, Co. Louth, Ireland. Headquartered in Wuxi city, Jiangsu province, China, WuXi Biologics is a global platform company providing services for biologics discovery, development and manufacturing. This state-of-the-art facility will employ multiple single-use bioreactors for commercial biomanufacturing and is designed to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters